Synergy Vaccines Announces Collaboration with BD Technologies

Apr 10, 2001, 01:00 ET from Synergy Vaccines

    RESEARCH TRIANGLE PARK, N.C., April 10 /PRNewswire/ --
     Synergy Vaccines, an RTP biotech startup incubating at BD Technologies
 (BDT) for the past two years has begun collaboration with BDT's advanced
 vaccine delivery group.  Synergy has developed very promising formulation
 technology, which greatly improves the efficacy of, advanced vaccines for life
 threatening diseases such as HIV and cancer.   The two companies are now
 engaged in a program to formulate and deliver vaccines to combat the spread of
 HIV, hepatitis B, and other pandemic diseases.
     BD Technologies is a technology and enterprise development center for
 BD (Becton, Dickinson and Company) dedicated to the development of leading
 edge medical technologies.  BDT is currently engaged in the development and
 application of new platforms for biotech drug and vaccine delivery, cellular
 and tissue therapies, molecular/cellular diagnostics, and IT/"smart product"
 based health care.
     BDT collaborates with startup biotech businesses by "incubating" selected
 companies with emerging medical technologies that are synergistic with its
 business growth strategy.  At present, four innovative startups reside within
 the BDT facility.  BDT's incubator arrangement is unique in that it provides
 not only laboratory and office space, but also affords the incubatee the
 opportunity to collaborate with BD's leading scientists.
 
 

SOURCE Synergy Vaccines
    RESEARCH TRIANGLE PARK, N.C., April 10 /PRNewswire/ --
     Synergy Vaccines, an RTP biotech startup incubating at BD Technologies
 (BDT) for the past two years has begun collaboration with BDT's advanced
 vaccine delivery group.  Synergy has developed very promising formulation
 technology, which greatly improves the efficacy of, advanced vaccines for life
 threatening diseases such as HIV and cancer.   The two companies are now
 engaged in a program to formulate and deliver vaccines to combat the spread of
 HIV, hepatitis B, and other pandemic diseases.
     BD Technologies is a technology and enterprise development center for
 BD (Becton, Dickinson and Company) dedicated to the development of leading
 edge medical technologies.  BDT is currently engaged in the development and
 application of new platforms for biotech drug and vaccine delivery, cellular
 and tissue therapies, molecular/cellular diagnostics, and IT/"smart product"
 based health care.
     BDT collaborates with startup biotech businesses by "incubating" selected
 companies with emerging medical technologies that are synergistic with its
 business growth strategy.  At present, four innovative startups reside within
 the BDT facility.  BDT's incubator arrangement is unique in that it provides
 not only laboratory and office space, but also affords the incubatee the
 opportunity to collaborate with BD's leading scientists.
 
 SOURCE  Synergy Vaccines